{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T14:56:08Z","timestamp":1703084168389},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12072-019-10000-5","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T13:02:34Z","timestamp":1574341354000},"page":"1-4","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Change in antibiotic regimen for emerging multidrug resistance in nosocomial ascitic fluid infection"],"prefix":"10.1007","volume":"14","author":[{"given":"Seema","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"10000_CR1","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009;49:2087\u20132107","journal-title":"Hepatology"},{"issue":"5","key":"10000_CR2","doi-asserted-by":"publisher","first-page":"1368.e10","DOI":"10.1053\/j.gastro.2018.12.005","volume":"156","author":"S Piano","year":"2019","unstructured":"Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, International Club of Ascites Global Study Group, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology 2019;156(5):1368.e10\u20131380.e10","journal-title":"Gastroenterology."},{"key":"10000_CR3","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3748\/wjg.v22.i15.4049","volume":"22","author":"A Alexopoulou","year":"2016","unstructured":"Alexopoulou A, Vasilieva L, Agiasotelli D, Siranidi K, Pouriki S, Tsiriga A, et al. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. World J Gastroenterol 2016;22:4049\u20134056","journal-title":"World J Gastroenterol."},{"key":"10000_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12072-019-09968-x","volume":"9","author":"SK Singh","year":"2019","unstructured":"Singh SK, Poddar U, Mishra R, Srivastava A, Yachha SK. Ascitic fluid infection in children with liver disease: time to change empiricalantibiotic policy. Hepatol Int 2019;9:45. https:\/\/doi.org\/10.1007\/s12072-019-09968-x(Epub ahead of print)","journal-title":"Hepatol Int."},{"issue":"5","key":"10000_CR5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.25532","volume":"55","author":"J Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012;55(5):1551\u20131561","journal-title":"Hepatology."},{"key":"10000_CR6","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/hep.27941","volume":"63","author":"S Piano","year":"2016","unstructured":"Piano S, Fasolato S, Salinas F, Romano A, Tonon M, Morando F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatology 2016;63:1299\u20131309","journal-title":"Hepatology."},{"issue":"11","key":"10000_CR7","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/jac\/dky323","volume":"73","author":"J Su","year":"2018","unstructured":"Su J, Guo Q, Li Y, Wu S, Hu F, Xu S, et al. Comparison of empirical therapy with cefoperazone\/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae. J Antimicrob Chemother 2018;73(11):3176\u20133180","journal-title":"J Antimicrob Chemother."},{"issue":"10","key":"10000_CR8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/jama.2018.12163","volume":"320","author":"MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN)","year":"2018","unstructured":"MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA 2018;320(10):984\u2013994","journal-title":"JAMA"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-019-10000-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-019-10000-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-019-10000-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T03:52:56Z","timestamp":1605844376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-019-10000-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10000"],"URL":"https:\/\/doi.org\/10.1007\/s12072-019-10000-5","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}